Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06590402 · ClinicalTrials.gov registry record · Phase 4
Anterior Femoral and Adductor Canal Nerve Blocks in Peds Knees
A Phase 4 study of Anterior Cruciate Ligament Reconstruction and Medial Patellofemoral Ligament Reconstruction, sponsored by Hospital for Special Surgery, New York.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06590402 is a Phase 4 study of Anterior Cruciate Ligament Reconstruction and Medial Patellofemoral Ligament Reconstruction that is actively recruiting participants, run by Hospital for Special Surgery, New York. The registered enrollment target is 60 participants, below the 289-participant average among 11 other Anterior Cruciate Ligament Reconstruction trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06590402, a Phase 4 study of Anterior Cruciate Ligament Reconstruction and Medial Patellofemoral Ligament Reconstruction, is actively recruiting participants, sponsored by Hospital for Special Surgery, New York.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this pilot clinical trial is to compare anterior femoral cutaneous nerve block (AFCN) to adductor canal block ACB) for pediatric patients undergoing either anterior cruciate ligament (ACL) or medial patellofemoral ligament (MPFL). The aims of this trial are: * To measure postoperative functional outcomes in patients who received AFCNB vs. ACB. * To calculate postoperative opioid requirements in pediatric knee surgeries that received AFCNB vs. ACB. * To calculate pain intensity levels at rest and with ambulation in patients who received AFCNB vs. ACB. * To quantify sensory deficits in patients who received AFCNB vs. ACB. * To assess patient-reported outcome measures (e.g., pain expectation scale, pain management satisfaction, PROMIS Pediatric Short Form v1.0 - Physical Activity, PROMIS Scale v1.2 - Global Health) in patients 8-18 years of age who received AFCNB vs. ACB. Subjects undergoing ACL procedures will be compared between those who received the adductor canal block to those who received the anterior femoral cutaneous nerve block. The researchers will also compare individuals who underwent MPFL procedures and received an anterior femoral cutaneous nerve block with those who received the adductor canal block. Participants will: * Be randomized to receive either the AFCNB or ACB in addition to standard of care analgesia. * Maintain a patient diary to document daily pain meds/pain scores * Complete follow up surveys/questionnaires via telephone and during their office visits with surgeons.
Conditions Studied
Interventions
- DRUG Bupivacaine, Dexamethasone in Adductor Canal Block
- DRUG Bupivacaine, Dexamethasone in Anterior Femoral Cutaneous Nerve Block
Study Locations (1)
New York
- Hospital for Special Surgery - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-06-06 |
| Est. Completion | 2028-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06590402
The ClinicalTrials.gov registry entry for NCT06590402 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 289-participant average among 11 other Anterior Cruciate Ligament Reconstruction trials with a reported enrollment target (79% lower). The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Anterior Cruciate Ligament Reconstruction appearing as the primary indexed condition, and to 2 interventions - of which Bupivacaine, Dexamethasone in Adductor Canal Block is the first listed.
NCT06590402 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06590402 about?
NCT06590402 is a clinical study titled "Anterior Femoral and Adductor Canal Nerve Blocks in Peds Knees". The goal of this pilot clinical trial is to compare anterior femoral cutaneous nerve block (AFCN) to adductor canal block ACB) for pediatric patients undergoing either anterior cruciate ligament (ACL) or medial patellofemoral ligament (MPFL). The aims of this trial are: * To measure postoperative f...
What is the current status of trial NCT06590402?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2025-06-06. Estimated completion is 2028-01.
What conditions does trial NCT06590402 study?
This clinical trial studies the following conditions: Anterior Cruciate Ligament Reconstruction, Medial Patellofemoral Ligament Reconstruction.
What interventions are being tested in trial NCT06590402?
The interventions under investigation include: Bupivacaine, Dexamethasone in Adductor Canal Block (DRUG), Bupivacaine, Dexamethasone in Anterior Femoral Cutaneous Nerve Block (DRUG).
Who is sponsoring clinical trial NCT06590402?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06590402 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anterior Cruciate Ligament Reconstruction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Anterior Cruciate Ligament Pain Study
COMPLETED · Phase 4
-
Comparing Subsartorial Saphenous Nerve Blocks With and Without Dexamethasone for Anterior Cruciate Ligament Reconstruction
COMPLETED · Phase 4
-
The Effects of Tranexamic Acid on Joint Inflammation and Cartilage Health in Anterior Cruciate Ligament Injured Patients
RECRUITING · Phase 2
-
Mental Imagery to Improve Quadriceps Strength Post Anterior Cruciate Ligament Reconstruction: a Feasibility Study
RECRUITING · NA
-
Anterior Cruciate Ligament (ACL) Reconstruction With Autologous Fat Pad Derived Mesenchymal Stem Cells
RECRUITING · Phase 1
-
Assessment of Gait Adaptation Due to an Asymmetric Walking Protocol
RECRUITING · NA
Explore more on PlainTrial
Anterior Cruciate Ligament Reconstruction
All registered trials for this condition
Medial Patellofemoral Ligament Reconstruction
All registered trials for this condition
New York
All trials with a study site in New York
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.